BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cellectis 

8 rue de la Croix Jarry

Paris    75013  France
Phone: 33-0-1-81-69-16-00 Fax: n/a


SEARCH JOBS




Industry
Biotechnology

Segment
Genomics





 Company News
Cellectis (ALCLS) R&D / Analyst Day 6/25/2014 11:20:05 AM
Cellectis (ALCLS)’ UCART19 Receives Advanced-Therapy Medicinal Product Classification From European Medicines Agency 6/23/2014 11:07:03 AM
Cellectis (ALCLS) To Participate In The Piper Jaffray GenomeRx Symposium On June 23, 2014 6/19/2014 10:30:13 AM
French Biotech Cellectis (ALCLS) Surges As Pfizer Inc. (PFE) Signs Cancer Immunotherapy Pact Worth $265 Million 6/18/2014 6:22:51 AM
Cellectis Enters Into An Agreement With CELLforCURE For The cGMP Manufacturing Of Allogeneic CART Cells 6/9/2014 11:10:44 AM
Cellectis And Accelera (Nerviano Medical Sciences (NervianoMS)) Sign An Agreement To Complete Preclinical Studies Of Cellectis’ Lead Product Candidate UCART19 6/5/2014 12:47:32 PM
Cellectis And Thermo Fisher Scientific (TMO) Enter Into Agreements On TALEN™, A Leading Gene Editing Technology 6/5/2014 9:09:31 AM
Cellectis Will Be Present At The American Society of Clinical Oncology Annual Meeting 5/27/2014 11:10:23 AM
Cellectis Announces The Closing Of €20.5 Million Share Capital Increase Subscribed On March 24, 2014 By U.S. Biotechnology Specialist Institutional Investors 4/1/2014 6:56:05 AM
Cellectis, Servier Forge Leukemia, Solid Tumors Pact To Battle With Novartis AG (NVS) And Newbie Juno Therapeutics 2/18/2014 7:39:15 AM
12345678910...